| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.081 | 0.06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.078 | 0.08 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.047 | 0.3 |